PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
30-Jan-2020 Autolus' Chief Scientific Officer, Dr Martin Pulé, to give Keynote Lecture at the EHA-EBMT 2nd European CAR T Cell Meeting Autolus Therapeutics plc
30-Jan-2020 Cresset joins 3D-NEONET consortium to help accelerate the development of novel therapeutics in cancer and ophthalmology Cresset
29-Jan-2020 Caroline Benson and Colin Williams to Co-Chair the PM Society from 2020 The PM Society
29-Jan-2020 Most innovative cancer drugs facing delays in reaching patients The Institute of Cancer Research
29-Jan-2020 Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis Sanofi
29-Jan-2020 Kite, a Gilead Company, to present latest cell therapy research at the 2nd European CAR T Cell Meeting, Sitges, Spain Gilead
29-Jan-2020 Most innovative cancer drugs facing delays in reaching patients The Institute of Cancer Research
29-Jan-2020 New Interactive Good Clinical Practice online learning course now available Jo Burmester
29-Jan-2020 Immutep activities report - late-stage Phase IIb metastatic breast cancer results ETA, TACTI-002 results ETA Immutep Limited
29-Jan-2020 Signant Health Enhances Audit Trail Reporting CapabiliTrialMax® to Improve eCOA Data Integrity Monitoring Signant Health
29-Jan-2020 Nuvisan Pharma Services acquires Inamed GmbH Nuvisan Pharma Services
28-Jan-2020 Registration Opens for SMi’s 20th Annual Pain Therapeutics Conference SMi Group
27-Jan-2020 Hypertrophic Scars Therapeutics Pipeline Analysis, Clinical Trials and Developments Pharma Proff
24-Jan-2020 Dupixent®▼ (dupilumab), accepted for restricted use within NHS Wales for the treatment of moderate to severe atopic dermatitis in adolescents aged 12 years and over1 Sanofi
24-Jan-2020 Dupixent®▼ (dupilumab) available to treat adolescents with moderate to severe atopic dermatitis in Scotland1 Sanofi
24-Jan-2020 Sanofi Completes Acquisition of Synthorx, Inc. Sanofi
24-Jan-2020 Johnson & Johnson Announces $250 Million Commitment to Support Frontline Health Workers, Reaching 100 Million People by 2030 Davos
24-Jan-2020 Momentum of support builds for early lung cancer screening in Scotland Oncimmune
24-Jan-2020 Genmab Announces 2019 Net Sales Figures for DARZALEX® (daratumumab) and Achievement of USD 150 Million Sales Milestone in DARZALEX Collaboration with Janssen Genmab
24-Jan-2020 Global Contract Research Organisation Expands Services with Oracle Argus Cloud PharSafer